Table 7.
Results from multivariable Cox proportional hazards model reveals significant parameters assessing influence of receiving surgery, endocrine therapy, bone-targeted therapy, and histological subtype on bone metastasis survival (BMS). *Mixed- refers to patients with tumors displaying both ILC and IDC subtypes.
| Parameter | BMS |
|||
|---|---|---|---|---|
| P-value | 95% CI | Hazard Ratio | ||
| Received Surgery (ref = yes) | 0.003 | 1.24, 2.92 | 1.9 | |
| Endocrine Therapy (ref = no) | 0.02 | 0.14, 0.82 | 0.33 | |
| Bone-targeted therapy, n = 165 (ref = no) |
0.03 | 0.23, 0.93 | 0.46 | |
| Histological Subtype, n = 157 | ILC vs IDC | 0.23 | 0.76, 3.20 | 1.56 |
| Mixed* vs IDC | 0.001 | 1.65, 7.41 | 3.49 | |